Your browser doesn't support javascript.
loading
Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro.
Ferrari, Francesca; Bellone, Stefania; Black, Jonathan; Schwab, Carlton L; Lopez, Salvatore; Cocco, Emiliano; Bonazzoli, Elena; Predolini, Federica; Menderes, Gulden; Litkouhi, Babak; Ratner, Elena; Silasi, Dan-Arin; Azodi, Masoud; Schwartz, Peter E; Santin, Alessandro D.
  • Ferrari F; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. francesca.ferrari@yale.edu.
  • Bellone S; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. stefania.bellone@yale.edu.
  • Black J; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. jonathan.black@yale.edu.
  • Schwab CL; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. carlton.schwab@yale.edu.
  • Lopez S; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. salvatore.lopez@yale.edu.
  • Cocco E; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. emiliano.cocco@yale.edu.
  • Bonazzoli E; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. elena.bonazzoli@yale.edu.
  • Predolini F; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. ferica.predolini@yale.edu.
  • Menderes G; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. gulden.menderes@yale.edu.
  • Litkouhi B; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. babak.litkouhi@yale.edu.
  • Ratner E; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. elena.ratner@yale.edu.
  • Silasi DA; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. dan-arin.silasi@yale.edu.
  • Azodi M; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. masoud.azodi@yale.edu.
  • Schwartz PE; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. peter.shwartz@yale.edu.
  • Santin AD; Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA. alessandro.santin@yale.edu.
J Exp Clin Cancer Res ; 34: 123, 2015 Oct 17.
Article en En | MEDLINE | ID: mdl-26474755
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Uterinas / Carcinosarcoma / Moléculas de Adhesión Celular / Complejo CD3 / Anticuerpos Biespecíficos / Antígenos de Neoplasias / Antineoplásicos Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Uterinas / Carcinosarcoma / Moléculas de Adhesión Celular / Complejo CD3 / Anticuerpos Biespecíficos / Antígenos de Neoplasias / Antineoplásicos Límite: Aged / Female / Humans / Middle aged Idioma: En Año: 2015 Tipo del documento: Article